These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32713055)

  • 41. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe chronic renal failure in association with oxycodone addiction: a new form of fibrillary glomerulopathy.
    Hill P; Dwyer K; Kay T; Murphy B
    Hum Pathol; 2002 Aug; 33(8):783-7. PubMed ID: 12203209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polyvinylpyrrolidone deposition disease in patients with intravenous opioid use: a case series.
    Leh F; Stalund IV; Bjånes TK; Ohldieck C; Svarstad E; Leh S
    Hum Pathol; 2021 Oct; 116():102-111. PubMed ID: 34329652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An exploratory study of OxyContin use among individuals with substance use disorders.
    Levy MS
    J Psychoactive Drugs; 2007 Sep; 39(3):271-6. PubMed ID: 18159780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using the Slug Mucosal Irritation Assay to Investigate the Tolerability of Tablet Excipients on Human Skin in the Context of the Use of a Nipple Shield Delivery System.
    Kendall R; Lenoir J; Gerrard S; Scheuerle RL; Slater NK; Tuleu C
    Pharm Res; 2017 Apr; 34(4):687-695. PubMed ID: 28194635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug.
    Khan GM; Zhu JB
    J Control Release; 1999 Feb; 57(2):197-203. PubMed ID: 9971903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process.
    Karande AD; Heng PW; Liew CV
    Int J Pharm; 2010 Aug; 396(1-2):63-74. PubMed ID: 20558264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factitial cutaneous ulcers and nodules: the use of electron-probe microanalysis in diagnosis.
    Jackson RM; Tucker SB; Abraham JL; Millns JL
    J Am Acad Dermatol; 1984 Dec; 11(6):1065-9. PubMed ID: 6392366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Skin Popping" and "Shooter's Patch" As Manifestations of Intradermal Drug Abuse.
    Samynathan A; Saardi K; Akiska YM; Sadur A; Johnson S; Nasseri M
    Cureus; 2023 Sep; 15(9):e45251. PubMed ID: 37842500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Near IR spectroscopy to quantify the silica content and difference between silicified microcrystalline cellulose and physical mixtures of microcrystalline cellulose and silica.
    Buckton G; Yonemochi E
    Eur J Pharm Sci; 2000 Mar; 10(1):77-80. PubMed ID: 10699385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formation of Indomethacin-Saccharin Cocrystals during Wet Granulation: Role of Polymeric Excipients.
    Tanaka R; Duggirala NK; Hattori Y; Otsuka M; Suryanarayanan R
    Mol Pharm; 2020 Jan; 17(1):274-283. PubMed ID: 31756100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compatibility studies between carbamazepine and tablet excipients using thermal and non-thermal methods.
    Joshi BV; Patil VB; Pokharkar VB
    Drug Dev Ind Pharm; 2002 Jul; 28(6):687-94. PubMed ID: 12149961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ; Ellis MS
    JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmaceutical acrylic beads obtained by suspension polymerization containing cellulose nanowhiskers as excipient for drug delivery.
    Villanova JC; Ayres E; Carvalho SM; Patrício PS; Pereira FV; Oréfice RL
    Eur J Pharm Sci; 2011 Mar; 42(4):406-15. PubMed ID: 21241802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Simple method for quantitative determination of active polymorphous and amorphous drugs in drug products by fourier transform-Raman spectroscopy].
    Ueno T; Urakami K; Higashi A; Umemoto K; Godo M; Kitamura K
    Yakugaku Zasshi; 2005 Oct; 125(10):807-14. PubMed ID: 16205038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and Safety of Oxycodone Injection for Relieving Cancer Pain: A Study in Japan Consisting of Two Open Trials for Intravenous and Subcutaneous Administration.
    Yoshimoto T; Ryu E; Tomiyasu S; Hojo M; Kokubun H; Matoba M
    Biol Pharm Bull; 2018 Jun; 41(6):850-857. PubMed ID: 29526884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.